Dendritic NanoTechnologies Appoints Dow Chemical Licensing Manager to Board of Directors

30-Mar-2005

Dendritic NanoTechnologies Inc. (DNT) announced it has appointed Michael Pirc, a chemical engineer and licensing manager for The Dow Chemical Company, to the company's Board of Directors. In his capacity as Dow's business manager for the Dow Technology Licensing Business, Pirc has overseen licensing for a broad range of Dow's business ventures. At DNT, Pirc will help the company better position itself to engage companies that wish to license DNT's unique dendrimer technologies.

In January, DNT announced a strategic partnership with Dow and DNT investor Starpharma. This agreement means that DNT owns the world's broadest dendrimer patent portfolio (196 patents comprising 41 patent families).

"Thanks in part to Mike's efforts while heading technology licensing at Dow, DNT was able to acquire the majority of intellectual property in the dendrimer field," said Robert Berry, chief executive officer, Dendritic NanoTechnologies.

https://www.bionity.com/en/news/44694/dendritic-nanotechnologies-appoints-dow-chemical-licensing-manager-to-board-of-directors.html